1-3 of 3
Fariba Mozaffari, PhD
Close
Sort by
Journal Articles

T Cells from Chronic Lymphocytic Leukemia (CLL) Patients Display Dysregulated Expression of Immune Checkpoint Molecules and Activation Markers Mainly Restricted to CD4 + Cells and Correlated with Disease Activity

Marzia Palma, MDPhD, Giusy Gentilcore, MSc, Fariba Mozaffari, PhD, Kia Heimersson, Barbro Näsman-Glaser, Lotta Hansson, MD PhD, Anders Österborg, MDPhD, Håkan Mellstedt, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4132.
https://doi.org/10.1182/blood.V126.23.4132.4132
Published: 2015
Journal Articles

In Vivo Effects of Lenalidomide on T Cell Proliferation and Immune Checkpoint Molecules in Patients with Advanced Stage CLL: Results from a Phase II Study

Maria Winqvist, MD, Fariba Mozaffari, PhD, Marzia Palma, MD PhD, Sandra Eketorp Sylvan, MD PhD, Hakan Mellstedt, MD PhD, Anders Osterborg, MD PhD, Jeanette Lundin, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4164.
https://doi.org/10.1182/blood.V126.23.4164.4164
Published: 2015
Journal Articles

T Cells from Patients with Chronic Lymphocytic Leukaemia Prevent Apoptosis of Autologous CLL Cells in a Dose- and Cell:Cell-Contact Dependent Fashion; Rationale for New Therapeutic Possibilities.

Eva Rossmann, MD, PhD, Parviz Kokhaei, PhD, Fariba Mozaffari, PhD, Marzia Palma, MD, Anders Osterborg, MD, PhD, Hakan Mellstedt, MD, PhD, A. Raja Choudhury, MSc, PhD
Journal: Blood
Blood (2008) 112 (11): 2071.
https://doi.org/10.1182/blood.V112.11.2071.2071
Published: 2008